Noncanonical functions of EZH2 in triple-negative breast cancers

被引：0
|
作者：
Anwar, Talha [1 ]
Moore, Heather [1 ]
Bergholtz, Sarah [1 ]
Kleer, Celina [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4790
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers
    Yang, Cheng-Chieh
    LaBaff, Adam
    Wei, Yongkun
    Nie, Lei
    Xia, Weiya
    Huo, Longfei
    Yamaguchi, Hirohito
    Hsu, Yi-Hsin
    Hsu, Jennifer L.
    Liu, Dongping
    Lang, Jingyu
    Du, Yi
    Lien, Huang-Chun
    Li, Long-Yuan
    Deng, Rong
    Chan, Li-Chuan
    Yao, Jun
    Kleer, Celina G.
    Hortobagyi, Gabriel N.
    Hung, Mien-Chie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (06): : 1009 - U235
  • [22] CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
    Lei Nie
    Yongkun Wei
    Fei Zhang
    Yi-Hsin Hsu
    Li-Chuan Chan
    Weiya Xia
    Baozhen Ke
    Cihui Zhu
    Rong Deng
    Jun Tang
    Jun Yao
    Yu-Yi Chu
    Xixi Zhao
    Ye Han
    Junwei Hou
    Longfei Huo
    How-Wen Ko
    Wan-Chi Lin
    Hirohito Yamaguchi
    Jung-Mao Hsu
    Yi Yang
    Dean N. Pan
    Jennifer L. Hsu
    Celina G. Kleer
    Nancy E. Davidson
    Gabriel N. Hortobagyi
    Mien-Chie Hung
    Nature Communications, 10
  • [23] Expression of Cancer Stem Cell Markers Aldh1 and Ezh2 Are Increased in Triple Negative Breast Cancers
    Iqbal, J.
    Lau, K. W.
    Thike, A. A.
    Ahmed, S. S.
    Tan, P. H.
    LABORATORY INVESTIGATION, 2013, 93 : 47A - 47A
  • [24] Molecular Stratification of Triple-Negative Breast Cancers
    Perou, Charles M.
    ONCOLOGIST, 2010, 15 : 39 - 48
  • [25] Expression of Cancer Stem Cell Markers Aldh1 and Ezh2 Are Increased in Triple Negative Breast Cancers
    Iqbal, J.
    Lau, K. W.
    Thike, A. A.
    Ahmed, S. S.
    Tan, P. H.
    MODERN PATHOLOGY, 2013, 26 : 47A - 47A
  • [26] Clinicopathological characteristics of triple-negative breast cancers
    Yuka Sasaki
    Hitoshi Tsuda
    Breast Cancer, 2009, 16 : 254 - 259
  • [27] CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
    Nie, Lei
    Wei, Yongkun
    Zhang, Fei
    Hsu, Yi-Hsin
    Chan, Li-Chuan
    Xia, Weiya
    Ke, Baozhen
    Zhu, Cihui
    Deng, Rong
    Tang, Jun
    Yao, Jun
    Chu, Yu-Yi
    Zhao, Xixi
    Han, Ye
    Hou, Junwei
    Huo, Longfei
    Ko, How-Wen
    Lin, Wan-Chi
    Yamaguchi, Hirohito
    Hsu, Jung-Mao
    Yang, Yi
    Pan, Dean N.
    Hsu, Jennifer L.
    Kleer, Celina G.
    Davidson, Nancy E.
    Hortobagyi, Gabriel N.
    Hung, Mien-Chie
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [28] EZH2 inhibition re-sensitizes drug resistant triple-negative breast cancer PDX models to Eribulin
    Bozek, Kathryn
    Darini, Cedric
    Lan, Cathy
    Buchanan, Marguerite
    Chabot, Catherine
    Lafleur, Josiane
    Guay, Juliet
    Filosa, Eva
    Aguilar-Mahecha, Adriana
    Basik, Mark
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [29] Adjuvant treatments for triple-negative breast cancers
    Joensuu, H.
    Gligorov, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 40 - 45
  • [30] Molecular Stratification of Triple-Negative Breast Cancers
    Perou, Charles M.
    ONCOLOGIST, 2011, 16 : 61 - 70
12345